Distinct efficacy of pre-differentiated versus intact fetal mesencephalon-derived human neural progenitor cells in alleviating rat model of Parkinson's disease.
about
Gene expression profiling of embryonic human neural stem cells and dopaminergic neurons from adult human substantia nigraHypoxia promotes dopaminergic differentiation of mesenchymal stem cells and shows benefits for transplantation in a rat model of Parkinson's disease.Stem cells from human-exfoliated deciduous teeth can differentiate into dopaminergic neuron-like cellsReversal of chlorpyrifos neurobehavioral teratogenicity in mice by nicotine administration and neural stem cell transplantation.Applications of amniotic membrane and fluid in stem cell biology and regenerative medicine.Evaluation of neural plasticity in adult stem cells.Human neural stem cells migrate along the nigrostriatal pathway in a primate model of Parkinson's disease.Transplantation of Deprenyl-Induced Tyrosine Hydroxylase-Positive Cells Improves 6-OHDA-Lesion Rat Model of Parkinson's Disease: Behavioral and Immunohistochemical Evaluation.Frontiers in the surgical treatment of Parkinson's disease.Stem cell-derived dopamine neurons for brain repair in Parkinson's disease.Stem cell sources for regenerative medicine: the immunological point of view.Potential cellular and regenerative approaches for the treatment of Parkinson's disease.Isolation and propagation of neural stem cells in caprine (Capra hircus).Mesencephalic human neural progenitor cells transplanted into the neonatal hemiparkinsonian rat striatum differentiate into neurons and improve motor behaviour.Mechanism-based approaches for the reversal of drug neurobehavioral teratogenicity.Behavioral and histological characterization of intrahippocampal grafts of human bone marrow-derived multipotent progenitor cells in neonatal rats with hypoxic-ischemic injury.Reversal of chlorpyrifos neurobehavioral teratogenicity in mice by allographic transplantation of adult subventricular zone-derived neural stem cells.
P2860
Q34098187-2504A6F3-E5E4-4F72-9EC6-ED826D0F835BQ34559310-1DF39223-DB3D-4680-89E3-8221E9D492E4Q34776167-D0C7C741-B4F1-4964-B278-450B560EB053Q34997522-1733BC47-EF88-458E-9CF8-E1EC96C4966CQ36326880-F00EA80E-09E6-468A-B7A3-B436D7F11BD4Q36729333-BA22BA76-894C-4F70-BBB7-6E67C90E1A84Q36790299-C11FA4B4-1C3C-418B-8468-B5199D3F72ABQ36862636-85492D2E-3959-49E7-90BE-63F053BB9892Q37174039-817CED96-502E-455B-8902-F0249EAEF405Q37704372-ABA2C192-064F-46E0-A1A9-227220A573FAQ37877626-EA1FB6DB-4939-4437-B63E-B8FEA0F4C35AQ43198086-929E7B54-A20D-420D-8FD9-05ED60341594Q46911747-D6E0A77E-7E4E-4C4F-B7A1-066E4418BFA3Q48363320-6E227EE3-8F1F-45B9-A61C-1ED60FC76F0AQ48369756-32A120E8-267B-4E5F-AFB4-0C7A07CF8108Q48526496-A4B8B1C2-D999-4D40-A373-DC57D06318FAQ51869436-ECD27D21-D18E-400A-92B0-DA8E19A4AFE4
P2860
Distinct efficacy of pre-differentiated versus intact fetal mesencephalon-derived human neural progenitor cells in alleviating rat model of Parkinson's disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Distinct efficacy of pre-diffe ...... model of Parkinson's disease.
@en
type
label
Distinct efficacy of pre-diffe ...... model of Parkinson's disease.
@en
prefLabel
Distinct efficacy of pre-diffe ...... model of Parkinson's disease.
@en
P2093
P1476
Distinct efficacy of pre-diffe ...... t model of Parkinson's disease
@en
P2093
Huanqing Zhang
Linsong Li
Xiaomin Wang
P304
P356
10.1016/J.IJDEVNEU.2004.05.008
P50
P577
2004-06-01T00:00:00Z